Cita APA (7a ed.)
Durelli, L., Verdun, E., Barbero, P., Bergui, M., Versino, E., Ghezzi, A., . . . Zaffaroni, M. (2002). Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: Results of a 2-year prospective randomised multicentre study (INCOMIN). Lancet, 359(9316), 1453-1461.
Cita Chicago Style (17a ed.)
Durelli, Luca, Elisabetta Verdun, Pierangelo Barbero, Mauro Bergui, Elisabetta Versino, Angelo Ghezzi, Enrico Montanari, y Mauro Zaffaroni. "Every-other-day Interferon Beta-1b Versus Once-weekly Interferon Beta-1a for Multiple Sclerosis: Results of a 2-year Prospective Randomised Multicentre Study (INCOMIN)." Lancet 359, no. 9316 (2002): 1453-1461.
Cita MLA (9a ed.)
Durelli, Luca, et al. "Every-other-day Interferon Beta-1b Versus Once-weekly Interferon Beta-1a for Multiple Sclerosis: Results of a 2-year Prospective Randomised Multicentre Study (INCOMIN)." Lancet, vol. 359, no. 9316, 2002, pp. 1453-1461.
Precaución: Estas citas no son 100% exactas.